Giotto to Demo Newly Cleared Mammo Systems
Giotto USA will be demonstrating at RSNA 2011 its 3D and 3DL digital mammography systems, which recently received FDA 510(k) clearance.
Giotto USA will be demonstrating at RSNA 2011 its 3D and 3DL digital mammography systems, which recently received FDA 510(k) clearance.
The Giotto systems include a ring-shaped tilting gantry, which the company said provides for patient-friendly face-to-face positioning and easier positioning for the technologist. The 3D has an 18 x 24 cm bucky, and the 3DL has a 24 x 30 cm bucky.
Other features of the systems include Insight View, Giotto’s new image processing software with the second generation Selenium Detector technology, inclined positioning for better visualization, and the opportunity to add the Biopsy Digit stereotactic biopsy device.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
